EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus

Giuliana Eboli Sotorilli iD, Humberto Doriguetto Gravina iD, Ana Carolina de Carvalho iD, Jacqueline Farinha Shimizu, Marina Alves Fontoura iD, Talita Diniz Melo-Hanchuk, Artur Torres Cordeiro, Rafael Elias Marques iD

Viruses · 2023

DOI: 10.3390/v15122416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Giuliana Eboli Sotorilli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-100, Brazil. Hauptthemen laut MEDLINE: Encephalitis, St. Louis, Triparanol, Flavivirus, Malaria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Financiadora de Estudos e Projetos, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

St. Louis encephalitis virus (SLEV) is a neglected mosquito-borne Flavivirus that may cause severe neurological disease in humans and other animals. There are no specific treatments against SLEV infection or disease approved for human use, and drug repurposing may represent an opportunity to accelerate the development of treatments against SLEV. Here we present a scalable, medium-throughput phenotypic cell culture-based screening assay on Vero CCL81 cells to identify bioactive compounds that could be repurposed against SLEV infection. We screened eighty compounds from the Medicines for Malaria Venture (MMV) COVID Box library to identify nine (11%) compounds that protected cell cultures from SLEV-induced cytopathic effects, with low- to mid-micromolar potencies. We validated six hit compounds using viral plaque-forming assays to find that the compounds ABT-239, Amiodarone, Fluphenazine, Posaconazole, Triparanol, and Vidofludimus presented varied levels of antiviral activity and selectivity depending on the mammalian cell type used for testing. Importantly, we identified and validated the antiviral activity of the anti-flavivirus nucleoside analog 7DMA against SLEV. Triparanol and Fluphenazine reduced infectious viral loads in both Vero CCL81 and HBEC-5i cell cultures and, similar to the other validated compounds, are likely to exert antiviral activity through a molecular target in the host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, St. LouisTriparanolFlavivirusMalariaAnimalsHumansEncephalitis Virus, St. LouisFluphenazineAntiviral AgentsMammals

Stichwörter der Autor:innen

FlavivirusSt. Louis encephalitis viruscationic amphiphilic compounds (CAD)cell culture-based screeningdrug repurposing

Substanzen

FluphenazineTriparanolAntiviral Agents

Autor:innen und Institutionen

  • Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-100, Brazil.
  • Department of Genetics, Microbiology and Immunology, Institute of Biology, State University of Campinas (UNICAMP), Campinas 13083-100, Brazil.
  • Department of Cellular and Structural Biology, Institute of Biology, State University of Campinas (UNICAMP), Campinas 13083-100, Brazil.

ORCID-Profile: Giuliana Eboli Sotorilli, Humberto Doriguetto Gravina, Ana Carolina de Carvalho, Marina Alves Fontoura, Rafael Elias Marques

Förderung

  • São Paulo Research Foundation
  • Financiadora de Estudos e Projetos
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • National Council for Scientific and Technological Development
  • FAPESP
  • FINEP
  • CAPES PROEX MSc Scholarship
  • FAPESP PhD Scholarship

Zitieren

APA

Sotorilli, G. E., Gravina, H. D., de Carvalho, A. C., Shimizu, J. F., Fontoura, M. A., Melo-Hanchuk, T. D., Cordeiro, A. T., & Marques, R. E. (2023). Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus. Viruses. https://doi.org/10.3390/v15122416

Vancouver

Sotorilli GE, Gravina HD, de Carvalho AC, Shimizu JF, Fontoura MA, Melo-Hanchuk TD, et al. Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus. Viruses. 2023. doi:10.3390/v15122416

BibTeX
@article{Sotorilli2023,
  author = {Sotorilli, Giuliana Eboli and Gravina, Humberto Doriguetto and de Carvalho, Ana Carolina and Shimizu, Jacqueline Farinha and Fontoura, Marina Alves and Melo-Hanchuk, Talita Diniz and Cordeiro, Artur Torres and Marques, Rafael Elias},
  title = {Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122416}
}
Kostenlos starten →